These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32111007)
1. Conformational Switching in Bcl-xL: Enabling Non-Canonic Inhibition of Apoptosis Involves Multiple Intermediates and Lipid Interactions. Vasquez-Montes V; Kyrychenko A; Vargas-Uribe M; Rodnin MV; Ladokhin AS Cells; 2020 Feb; 9(3):. PubMed ID: 32111007 [TBL] [Abstract][Full Text] [Related]
2. Lipid-modulation of membrane insertion and refolding of the apoptotic inhibitor Bcl-xL. Vasquez-Montes V; Vargas-Uribe M; Pandey NK; Rodnin MV; Langen R; Ladokhin AS Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):691-700. PubMed ID: 31004798 [TBL] [Abstract][Full Text] [Related]
3. Membrane interactions of apoptotic inhibitor Bcl-xL: What can be learned using fluorescence spectroscopy. Kyrychenko A; Ladokhin AS BBA Adv; 2023; 3():100076. PubMed ID: 37082264 [TBL] [Abstract][Full Text] [Related]
4. Evidence that membrane insertion of the cytosolic domain of Bcl-xL is governed by an electrostatic mechanism. Thuduppathy GR; Craig JW; Kholodenko V; Schon A; Hill RB J Mol Biol; 2006 Jun; 359(4):1045-58. PubMed ID: 16650855 [TBL] [Abstract][Full Text] [Related]
5. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL. Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046 [TBL] [Abstract][Full Text] [Related]
6. Effects of Cardiolipin on the Conformational Dynamics of Membrane-Anchored Bcl-xL. Tyagi V; Vasquez-Montes V; Freites JA; Kyrychenko A; Tobias DJ; Ladokhin AS Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502299 [TBL] [Abstract][Full Text] [Related]
7. Comparison of membrane insertion pathways of the apoptotic regulator Bcl-xL and the diphtheria toxin translocation domain. Vargas-Uribe M; Rodnin MV; Ladokhin AS Biochemistry; 2013 Nov; 52(45):7901-9. PubMed ID: 24134052 [TBL] [Abstract][Full Text] [Related]
8. Acid destabilization of the solution conformation of Bcl-xL does not drive its pH-dependent insertion into membranes. Thuduppathy GR; Hill RB Protein Sci; 2006 Feb; 15(2):248-57. PubMed ID: 16385002 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the membrane-inserted C-terminus of cytoprotective BCL-XL. Yao Y; Nisan D; Fujimoto LM; Antignani A; Barnes A; Tjandra N; Youle RJ; Marassi FM Protein Expr Purif; 2016 Jun; 122():56-63. PubMed ID: 26923059 [TBL] [Abstract][Full Text] [Related]
10. NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL. Malia TJ; Wagner G Biochemistry; 2007 Jan; 46(2):514-25. PubMed ID: 17209561 [TBL] [Abstract][Full Text] [Related]
11. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria. Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439 [TBL] [Abstract][Full Text] [Related]
12. Conformation of BCL-XL upon Membrane Integration. Yao Y; Fujimoto LM; Hirshman N; Bobkov AA; Antignani A; Youle RJ; Marassi FM J Mol Biol; 2015 Jul; 427(13):2262-70. PubMed ID: 25731750 [TBL] [Abstract][Full Text] [Related]
13. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis. Rajan S; Choi M; Baek K; Yoon HS Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960 [TBL] [Abstract][Full Text] [Related]
14. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl. Xu H; Tai J; Ye H; Kang CB; Yoon HS Biochem Biophys Res Commun; 2006 Mar; 341(4):938-44. PubMed ID: 16455050 [TBL] [Abstract][Full Text] [Related]
15. Effect of the structural difference between Bax-α5 and Bcl-xL-α5 on their interactions with lipid bilayers. Han E; Lee H Phys Chem Chem Phys; 2014 Jan; 16(3):981-8. PubMed ID: 24281254 [TBL] [Abstract][Full Text] [Related]
16. The N-terminal domain of Bcl-xL reversibly binds membranes in a pH-dependent manner. Thuduppathy GR; Terrones O; Craig JW; Basañez G; Hill RB Biochemistry; 2006 Dec; 45(48):14533-42. PubMed ID: 17128992 [TBL] [Abstract][Full Text] [Related]
17. Discoveries and controversies in BCL-2 protein-mediated apoptosis. Zheng JH; Viacava Follis A; Kriwacki RW; Moldoveanu T FEBS J; 2016 Jul; 283(14):2690-700. PubMed ID: 26411300 [TBL] [Abstract][Full Text] [Related]
18. Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain. Vervliet T; Lemmens I; Vandermarliere E; Decrock E; Ivanova H; Monaco G; Sorrentino V; Nadif Kasri N; Missiaen L; Martens L; De Smedt H; Leybaert L; Parys JB; Tavernier J; Bultynck G Sci Rep; 2015 Apr; 5():9641. PubMed ID: 25872771 [TBL] [Abstract][Full Text] [Related]
19. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL. Yamaguchi H; Wang HG J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137 [TBL] [Abstract][Full Text] [Related]
20. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft. Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]